Literature DB >> 28266307

In Reply.

Joachim Mössner.   

Abstract

Year:  2017        PMID： 28266307      PMCID： PMC5341117          DOI： 10.3238/arztebl.2017.0102

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN： 1866-0452            Impact factor:   5.594


× No keyword cloud information.
  5 in total

Review 1.  The Indications, Applications, and Risks of Proton Pump Inhibitors.

Authors:  Joachim Mössner
Journal:  Dtsch Arztebl Int       Date:  2016-07-11       Impact factor: 5.594

2.  The validity and reliability of the reflux finding score (RFS).

Authors:  P C Belafsky; G N Postma; J A Koufman
Journal:  Laryngoscope       Date:  2001-08       Impact factor: 3.325

3.  Rabeprazole is effective in treating laryngopharyngeal reflux in a randomized placebo-controlled trial.

Authors:  Paul K Y Lam; Manwa L Ng; Ting K Cheung; Birgitta Y H Wong; Victoria P Y Tan; Daniel Y T Fong; William I Wei; Benjamin C Y Wong
Journal:  Clin Gastroenterol Hepatol       Date:  2010-03-18       Impact factor: 11.382

4.  Low Prevalence of Hypomagnesemia in Long-term Recipients of Proton Pump Inhibitors in a Managed Care Cohort.

Authors:  Ala I Sharara; Jean M Chalhoub; Nijmeh Hammoud; Ali H Harb; Fayez S Sarkis; Ghassan Hamadeh
Journal:  Clin Gastroenterol Hepatol       Date:  2015-10-20       Impact factor: 11.382

5.  Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers. The role of gastric colonization.

Authors:  M R Driks; D E Craven; B R Celli; M Manning; R A Burke; G M Garvin; L M Kunches; H W Farber; S A Wedel; W R McCabe
Journal:  N Engl J Med       Date:  1987-11-26       Impact factor: 91.245
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.